Colonial Trust Advisors Trims Stake in Solventum Co. (NYSE:SOLV)

Colonial Trust Advisors cut its stake in Solventum Co. (NYSE:SOLV) by 51.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 431 shares of the company’s stock after selling 450 shares during the quarter. Colonial Trust Advisors’ holdings in Solventum were worth $28,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of SOLV. Modus Advisors LLC purchased a new position in Solventum during the 4th quarter valued at about $25,000. Stonebridge Financial Group LLC bought a new position in shares of Solventum during the fourth quarter valued at approximately $26,000. Crews Bank & Trust purchased a new position in shares of Solventum during the fourth quarter valued at approximately $32,000. Synergy Asset Management LLC bought a new stake in shares of Solventum in the 4th quarter worth approximately $35,000. Finally, Spire Wealth Management purchased a new stake in shares of Solventum in the 4th quarter worth approximately $37,000.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on SOLV shares. Piper Sandler lifted their price objective on Solventum from $75.00 to $84.00 and gave the company a “neutral” rating in a research note on Friday, February 28th. Mizuho upped their price target on shares of Solventum from $70.00 to $82.00 and gave the stock a “neutral” rating in a research note on Monday, March 3rd. The Goldman Sachs Group raised their price objective on shares of Solventum from $63.00 to $71.00 and gave the company a “sell” rating in a research note on Monday, March 3rd. Wells Fargo & Company upped their target price on shares of Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a research note on Friday, February 28th. Finally, Morgan Stanley raised their price target on shares of Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a research report on Wednesday, March 5th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $79.86.

Solventum Stock Down 4.8 %

Shares of Solventum stock opened at $65.30 on Friday. Solventum Co. has a twelve month low of $47.16 and a twelve month high of $85.92. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The company’s 50 day moving average is $74.36 and its 200 day moving average is $71.72. The company has a market cap of $11.30 billion and a price-to-earnings ratio of 23.75.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.